What limitations do many COPD patients face as they age?
- Ability to coordinate actuation and inhalation is difficult, especially as people age1
- The majority of patients were unable to use an MDI correctly, which may have compromised treatment1,2
- Dexterity decreases with age3,4
With an MDI (metered dose inhaler), why can coordination and dexterity be a concern?
- Almost 1/2 of patients rate their MDI difficult to use5,16
- Many patients lack the coordination and dexterity needed to use their MDI effectively1
- Although the majority of MDI patients had a spacer available, only 15%
Twice-daily BROVANA® (arformoterol tartrate) may be the right fit
- No hand/breath coordination required6
- No deep breaths or breath holding required6
- Minimal dexterity required6
When you want them to get back into daily living, BROVANA® (arformoterol tartrate) may be the right fit for COPD maintenance therapy
BROVANA, like other beta2-agonists, can produce a clinically significant cardiovasuclar effect in some patients as measured by increases in pulse rate, blood pressure, and/or symptoms.